Oxygen‐carrying semiconducting polymer nanoprodrugs induce sono‐pyroptosis for deep‐tissue tumor treatment

Abstract Sonodynamic therapy (SDT) has been explored for cancer therapy, especially for deep tumors due to its low tissue penetration restriction. The therapeutic efficacy of SDT is limited due to the complicated tumor microenvironment. This study reports the construction of oxygen‐carrying semiconducting polymer nanoprodrugs (OSPN pro ) for deep tumor treatment via combining amplified SDT with pyroptosis. An oxygen carrier perfluorohexane, sonodynamic semiconducting polymer as the sonosensitizer, and reactive oxygen species (ROS)‐responsive prodrug are co‐loaded into a nanoparticle system, leading to the formation of these polymer nanoprodrugs. Such OSPN pro show an effective accumulation in tumor tissues after systemic administration, in which they deliver oxygen to relieve tumor hypoxia microenvironment and thus mediate amplified SDT via producing ROS under ultrasound (US) irradiation, even when the tumors are covered with a 2‐cm chicken breast tissue. In addition, the ROS‐responsive prodrugs are activated by the generated ROS to trigger pyroptosis of tumor cells. Such a sono‐pyroptosis induces a strong antitumor immunity with obviously higher level infiltrations of effector immune cells into tumors. Therefore, OSPN pro ‐based combinational therapy can greatly inhibit the growth of 2‐cm chicken breast tissue‐covered deep tumors and suppress tumor metastasis. This study offers a prodrug nanoplatform for treatment of deep tumor via sono‐pyroptosis strategy.